Immune memory cells found to target ovarian tumors, opening vaccine path

MEDICAL XPRESS

Researchers have shown for the first time that memory B cells — the immune system’s long-term defenders — can migrate from lymph nodes into ovarian tumors and produce antibodies targeting them. Over a third of those antibodies bound strongly to ovarian cancer cells, pointing to a new class of cancer vaccines.